EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals

Gergana Zahmanova iD, Alaa A A Aljabali iD, Katerina Takova, George Minkov, Murtaza M Tambuwala iD, Ivan Minkov iD, George P Lomonossoff iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417575 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Gergana Zahmanova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Plants, Influenza Vaccines. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund at the University of Plovdiv, European Union's Horizon 2020 research and innovation program, European Regional Development Fund through the Bulgarian "Science and Education for Smart Growth" Operational Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plants are increasingly used for the production of high-quality biological molecules for use as pharmaceuticals and biomaterials in industry. Plants have proved that they can produce life-saving therapeutic proteins (Elelyso™—Gaucher’s disease treatment, ZMapp™—anti-Ebola monoclonal antibodies, seasonal flu vaccine, Covifenz™—SARS-CoV-2 virus-like particle vaccine); however, some of these therapeutic proteins are difficult to bring to market, which leads to serious difficulties for the manufacturing companies. The closure of one of the leading companies in the sector (the Canadian biotech company Medicago Inc., producer of Covifenz) as a result of the withdrawal of investments from the parent company has led to the serious question: What is hindering the exploitation of plant-made biologics to improve health outcomes? Exploring the vast potential of plants as biological factories, this review provides an updated perspective on plant-derived biologics (PDB). A key focus is placed on the advancements in plant-based expression systems and highlighting cutting-edge technologies that streamline the production of complex protein-based biologics. The versatility of plant-derived biologics across diverse fields, such as human and animal health, industry, and agriculture, is emphasized. This review also meticulously examines regulatory considerations specific to plant-derived biologics, shedding light on the disparities faced compared to biologics produced in other systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlantsInfluenza VaccinesAnimalsHumansCanadaPharmaceutical PreparationsPlants, Genetically Modified

Stichwörter der Autor:innen

antibodiesgenome editingplant molecular farmingplant-based expression systemsplant-derived biologicssynthetic biologytherapeutic enzymesvaccinesvirus-like particles

Substanzen

Influenza VaccinesPharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.
  • Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
  • Lincoln Medical School, University of Lincoln, Brayford Pool Campus, Lincoln LN6 7TS, UK.
  • Institute of Molecular Biology and Biotechnologies, 4108 Markovo, Bulgaria.
  • Department of Biochemistry and Metabolism, John Innes Centre, Norwich NR4 7UH, UK.

ORCID-Profile: Gergana Zahmanova, Alaa A A Aljabali, Murtaza M Tambuwala, Ivan Minkov, George P Lomonossoff

Förderung

  • Research Fund at the University of Plovdiv
  • European Union's Horizon 2020 research and innovation program
  • European Regional Development Fund through the Bulgarian "Science and Education for Smart Growth" Operational Programme
  • BBSRC funded Institute Strategic Programme
  • European Union’s Horizon 2020 research and innovation program
  • European Regional Development Fund through the Bulgarian “Science and Education for Smart Growth” Operational Program
  • BBSRC-funded Institute Strategic Program

Zitieren

APA

Zahmanova, G., Aljabali, A. A. A., Takova, K., Minkov, G., Tambuwala, M. M., Minkov, I., & Lomonossoff, G. P. (2023). Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417575

Vancouver

Zahmanova G, Aljabali AAA, Takova K, Minkov G, Tambuwala MM, Minkov I, et al. Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417575

BibTeX
@article{Zahmanova2023,
  author = {Zahmanova, Gergana and Aljabali, Alaa A A and Takova, Katerina and Minkov, George and Tambuwala, Murtaza M and Minkov, Ivan and Lomonossoff, George P},
  title = {Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417575}
}
Kostenlos starten →